Open access peer-reviewed chapter

Maffucci Syndrome

By Miki Tanioka

Submitted: March 20th 2012Reviewed: October 22nd 2012Published: February 6th 2013

DOI: 10.5772/54570

Downloaded: 1299

1. Introduction

Maffucci syndrome is characterized by the presence of multiple enchondromas associated with multiple hemangiomas (figure 1). Enchondromas are common benign cartilage tumors of bone. They can occur as solitary lesions or as multiple lesions in enchondromatosis(Schwartz 1987, Kaplan 1993). When hemangiomata are associated, the condition is known as Maffucci syndrome (figure 2). The patients are normal at birth and the syndrome manifests during childhood and puberty. The enchondromas affect the extremities and their distribution is asymmetrical. The most common sites of enchondromas are the metacarpal bones and phalanges of the hands. The feet are less commonly afflicted. Clinical problems caused by enchondromas include skeletal deformity and the potential for malignant change to osteosarcoma (figure 3). The risk for sarcomatous degeneration of enchondromas, hemangiomas, or lymphangiomas is 15-30%. Maffucci syndrome is also associated with a higher risk of CNS, pancreatic, and ovarian malignancies (Ono 2012) (figure 4).

Figure 1.

Multiple enchondromas

Figure 2.

Multiple hemangioma on the sole

Figure 3.

The differences of length and size of the legs are noted.

Figure 4.

Brain tumor in a patient with Maffucci syndrome

2. Inheritance

Most cases of Maffucci syndrome have been sporadic and no specific hereditary form has been proven (Hakak and Azouz 1991).

It occurs in all races, and occurs in both sexes equally.

3. Cutaneous presentation of Maffucci syndrome

Multiple hemangiomas are presented as multiple nodules on the skin of the extremities, which looks like grapes (figure 2). However, the sites of hamangiomas are reported to be the colon and brain (Lee 1999). Multiple enchondromas present as a subcutaneous nodules fix to the underlining bones. Bleeding from the hemangiomas is clinically important and difficult to manage. Complete resection is usually impossible. Compression therapy is recommended.

4. Melecular genetics of Maffucci syndrome

The responsible genes for Maffucci syndrome have not been found. However, some studies were reported for multiple enchondromatosis.

In enchondromas and chondrosarcomas, mutations of the PTHR1 gene was reported to be a candidate gene, however, subsequent studies could not confirm it (Hopyan 2002, Rozeman 2004).

Somatic heterozygous mutations in IDH1 or IDH2 were reported in enchondromas and spindle cell hemangiomas (Pansuriya 2011). Ten cases of 13 (77%) with Maffucci syndrome carried IDH1 or IDH2 mutations in their tumors. IDH1 mutations in cartilage tumors were associated with hypermethylation and downregulated expression of several genes (Amary 2011). Mutations were absent in DNA isolated from the blood, muscle, or saliva of the subjects. Therefore, these mutations are believed to be somatic.

5. Management of Maffucci syndrome

Management entails careful examination and monitoring for malignant degenerations. Surgical interventions can correct or minimize deformities.

Compression therapy may be useful to control hemangiomas.

© 2013 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Miki Tanioka (February 6th 2013). Maffucci Syndrome, Current Genetics in Dermatology, Naoki Oiso, IntechOpen, DOI: 10.5772/54570. Available from:

chapter statistics

1299total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Nevoid Basal Cell Carcinoma Syndrome (NBCCS)

By Miki Tanioka

Related Book

First chapter

Evaluation of Patients with Alopecia

By Meda Sandra Orasan, Andrei Coneac and Iulia Ioana Roman

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us